P A
Bluelighter
I'm sure this has been dealt with before, so I apologize for any redundancy, but what's with the deal with this popular meth-hate among amateur pharmacology enthusiasts? I hear talk of substantially more egregious toxicity than dextroamphetamine at equivalent doses and see little substantiation, apart from d-methamphetamine's comparatively higher [though still meager] affinity for the serotonin transporter.
Aside from the moderately increased risk of hyperthermia at equipotent dosages [via downstream postsynaptic 5-HT2A agonism], what relevance does meth's still-weak serotonergic properties actually have? Or is this just another oft-repeated myth of 'intelligent' drug culture?
(Kinda relevant: My interest stems from the fact that I plan on replacing my p.r.n. 20mg Dextrostat dose with a 10mg tablet of Desoxyn for regular use - are my concerns even justified at such a low dose? If so, why?)
Aside from the moderately increased risk of hyperthermia at equipotent dosages [via downstream postsynaptic 5-HT2A agonism], what relevance does meth's still-weak serotonergic properties actually have? Or is this just another oft-repeated myth of 'intelligent' drug culture?
(Kinda relevant: My interest stems from the fact that I plan on replacing my p.r.n. 20mg Dextrostat dose with a 10mg tablet of Desoxyn for regular use - are my concerns even justified at such a low dose? If so, why?)
